Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Cell Reports|October 20, 2023
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherinRodrigo I Santos, Philipp A Ilinykh, Colette A Pietzsch, et al.
Journal of Virology|April 13, 2007
Successful topical respiratory tract immunization of primates against Ebola virusAlexander Bukreyev, Pierre E Rollin, Mallory K Tate, et al.
Mbio|September 28, 2017
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine StormPatrick Younan, Mathieu Iampietro, Andrew Nishida, et al.
Lancet (London, England)|June 29, 2004
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARSAlexander Bukreyev, Elaine W Lamirande, Ursula J Buchholz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infectionJohn S Tregoning, Belinda Lei Wang, Jacqueline U McDonald, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antiviralsJingru Fang, Colette Pietzsch, Haydar Witwit, et al.
Antiviral Research|January 3, 2018
A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replicationPriya Luthra, Jue Liang, Colette A Pietzsch, et al.
The Journal of Clinical Investigation|July 3, 2025
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccineChandru Subramani, Michelle Meyer, Matthew A Hyde, et al.
The Journal of Clinical Investigation|July 14, 2015
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesMichelle Meyer, Tania Garron, Ndongala M Lubaki, et al.
The Journal of Infectious Diseases|September 1, 2018
Protein Phosphatase 1-Targeting Small-Molecule C31 Inhibits Ebola Virus ReplicationTatiana Ammosova, Colette A Pietzsch, Yasemin Saygideger, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Cell Reports|October 20, 2023
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherinRodrigo I Santos, Philipp A Ilinykh, Colette A Pietzsch, et al.
Journal of Virology|April 13, 2007
Successful topical respiratory tract immunization of primates against Ebola virusAlexander Bukreyev, Pierre E Rollin, Mallory K Tate, et al.
Mbio|September 28, 2017
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine StormPatrick Younan, Mathieu Iampietro, Andrew Nishida, et al.
Lancet (London, England)|June 29, 2004
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARSAlexander Bukreyev, Elaine W Lamirande, Ursula J Buchholz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infectionJohn S Tregoning, Belinda Lei Wang, Jacqueline U McDonald, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antiviralsJingru Fang, Colette Pietzsch, Haydar Witwit, et al.
Antiviral Research|January 3, 2018
A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replicationPriya Luthra, Jue Liang, Colette A Pietzsch, et al.
The Journal of Clinical Investigation|July 3, 2025
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccineChandru Subramani, Michelle Meyer, Matthew A Hyde, et al.
The Journal of Clinical Investigation|July 14, 2015
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesMichelle Meyer, Tania Garron, Ndongala M Lubaki, et al.
The Journal of Infectious Diseases|September 1, 2018
Protein Phosphatase 1-Targeting Small-Molecule C31 Inhibits Ebola Virus ReplicationTatiana Ammosova, Colette A Pietzsch, Yasemin Saygideger, et al.
Pageof 17